Estrogen reduces aldosterone, upregulates adrenal angiotensin II AT 2 receptors and normalizes adrenomedullary Fra-2 in ovariectomized rats

Neuroendocrinology

Volumn 88, Issue 4, 2008, Pages 276-286

  Macova, Miroslava ^a   Armando, Ines ^a   Zhou, Jin ^a   Baiardi, Gustavo ^a   Tyurmin, Dmitri ^a   Larrayoz Roldan, Ignacio M ^a   Saavedra, Juan M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adrenal cortex; Adrenal medulla; Aldosterone; Angiotensin II AT1 receptors; Fra 2; Renin angiotensin system; Reproductive hormones; Transcription factors; Tyrosine hydroxylase

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1B RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CATECHOLAMINE; ESTROGEN; MESSENGER RNA; TRANSCRIPTION FACTOR FRA 2; TYROSINE 3 MONOOXYGENASE;

ADRENAL CORTEX; ADRENAL GLAND; ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN THERAPY; FEMALE; FLUID RETENTION; MEDULLA OBLONGATA; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; ZONA GLOMERULOSA;

ADRENAL MEDULLA; ALDOSTERONE; ANIMALS; CATECHOLAMINES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOS-RELATED ANTIGEN-2; MODELS, ANIMAL; OVARIECTOMY; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; ZONA GLOMERULOSA;

EID: 57149092382     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000150977     Document Type: Article

References (75)

1. Corvol P, Jeunemaitre X, Charru A, Kotelevtsev Y, Soubrier F: Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog Horm Res 1995;50:287-308.
2. Castelli WP: Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-1560.
3. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA: Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
4. Harvey PJ, Wing LM, Savage J, Molloy D: The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women. J Hypertens 1999;17:405-411.
5. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J; Randomized Aldactone Evaluation Study investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-717.
6. +-induced aldosterone secretion from human adrenocortical NCI-H295 cells. Hypertension 1999;33:1025-1030.
7. 2 receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription. Endocrinology 2003;144:2092-2101.
8. Chiou CY, Kifor I, Moore TJ, Williams GH: The effect of losartan on potassium-stimulated aldosterone secretion in vitro. Endocrinology 1994;134:2371-2375.
9. Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Kobayashi M, Miyazaki H, Demura H: Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells. J Endocrinol Invest 1998;21:668-672.
10. Naruse M, Tanabe A, Sugaya T, Naruse K, Yoshimoto T, Seki T, Imaki T, Demura R, Murakami K, Demura H: Differential roles of angiotensin receptor subtypes in adrenocortical function in mice. Life Sci 1998;63:1593-1598.
11. Volpe M, Gigante B, Enea I, Porcellini A, Russo R, Lee MA, Magri P, Condorelli G, Savoia C, Lindpaintner K, Rubattu S: Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats. Circ Res 1997;81:857-864.
12. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD: Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun 1992;183:1090-1096.
13. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K: Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun. 1992;188:446-452.
14. Hano T, Mizukoshi M, Baba A, Nakamura N, Nishio I: Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland. Blood Press Suppl 1994;5:105-108.
15. Martineau D, Yamaguchi N, Briand R: Inhibition by BMS 186295, a selective non-peptide AT 1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo. Can J Physiol Pharmacol 1995;73:459-464.
16. Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB: Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther 1990;255:584-592.
17. Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W: Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats. Hypertension 1999;33:1201-1206.
18. Brownie AC: The adrenal cortex in hypertension: DOCA/salt hypertension and beyond; in Laragh JH (ed): Hypertension: Pathophysiology, Diagnosis, and Management. Philadelphia, Lippincott Williams & Wilkins, 1995.
19. Joffe HV, Adler GK: Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005;10:31-37.
20. 1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA. Endocrinology 1999;140:5435-5438.
21. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG, Sandberg K: Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 2000;141:4629-4636.
22. Serova LI, Maharjan S, Sabban EL: Estrogen modifies stress response of catecholamine biosynthetic enzyme genes and cardiovascular system in ovariectomized female rats. Neuroscience 2005;132:249-259.
23. Yanagihara N, Liu M, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y, Takahashi K, Tanaka K: Stimulation of catecholamine synthesis through unique estrogen receptors in the bovine adrenomedullary plasma membrane by 17β-estradiol. Biochem Biophys Res Commun 2006;339:548-553.
24. 125I]CGP 42112. Brain Res 1995;677:29-38.
25. Gallinat S, Busche S, Raizada MK, Sumners C: The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol 2000;278:E357-E374.
26. 1) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells. J Hypertens 2001;19:1991-1999.
27. 2 receptors. Neuroendocrinology 2002;75:227-240.
28. 2 receptors. Am J Physiol Renal Physiol 2002;283:F934-F943.
29. 2 receptors in the rat. Regul Pept 2005;124:7-17.
30. 2) in rat brain. Am J Physiol 1991;261:R209-R216.
31. 125I-labeled ligands in quantitative autoradiography. Neurosci Lett 1987;81:345-350.
32. Grima B, Lamouroux A, Blanot F, Biguet NF, Mallet J: Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc Natl Acad Sci USA 1985;82:617-621.
33. Wisden W, Morris BJ: In situ hybridization with synthetic oligonucleotide probes; in Wisden W, Morris BJ (eds): In situ Hybridization Protocols for the Brain. San Diego, Academic Press, 1994, pp 9-34.
34. 2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport 1995;6:2549-2552.
35. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 2001;142:3880-3889.
36. 1-subtype receptors. Hypertension 1997;30:563-568.
37. Butcher RL, Collins WE, Fugo NW: Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology 1974;94:1704-1708.
38. 1 receptor translation. Endocrinology 2003;144:3251-3261.
39. 1) receptor expression by PET. J Nucl Med 2004;45:94-100.
40. Suarez C, Díaz-Torga G, González-Iglesias A, Cristina C, Becu-Villalobos D: Upregulation of angiotensin II type 2 receptor expression in estrogen-induced pituitary hyperplasia. Am J Physiol 2004;286:E786-E794.
41. 2 receptors in human myometrium. J Clin Endocrinol Metab 1996;81:1753-1757.
42. 2 receptor gene expression by estrogen in ApoE/ERa knockout mice. Exp Physiol 2008;93:658-664.
43. 2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res 2004;62:587-593.
44. 1A receptor mRNA expression is induced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus. J Neurosci 1997;17:8283-8292.
45. 1A angiotensin receptor gene. Circ Res 1993;73:612-621.
46. Zheng W, Shi M, Yoo S-E, Ji H, Roesch DM: Estrogens contribute to a sex difference in plasma potassium concentration: a mechanism for regulation of adrenal angiotensin receptors. Gender Med 2006;3:43-53.
47. + depletion on forebrain and peripheral angiotensin II receptors in young rats. Brain Res 1991;556:240-246.
48. Kobayashi S, Ohnishi J, Nibu Y, Nishimatsu S, Umemura S, Ishii M, Murakami K, Miyazaki H: Cloning of the rat angiotensin II type 2 receptor gene and identification of its functional promoter region. Biochim Biophys Acta 1995;1262:155-158.
49. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, and Webb P: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000;74:311-317.
50. Ichiki T, Kambayashi Y, Inagami T: Transcription of the rat angiotensin II type 2 receptor gene. Biochem Biophys Res Commun 1996;222:566-571.
51. +-ATPase activity and spontaneous oscillations by 17β-estradiol. Chin J Physiol 2003;46:55-62.
52. Foster RH, Prat H, Rothman I: Is ouabain produced by the adrenal gland? Gen Pharm 1998;31:499-501.
53. Tamura M, Wanaka Y, Landon EJ, Inagami T: Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells. Hypertension 1999;33:626-632.
54. 2 receptors stimulate endogenous ouabain from adrenal glands. Hypertension 1997;29:401-407.
55. 2 receptor gene-disrupted mice. Regul Pept 2001;102:41-47.
56. 2 receptor gene-disrupted mice. Am J Physiol Renal Physiol 2001;280:F71-F78.
57. 2 receptor gene disrupted mice. Neuroendocrinology 2002;76:137-147.
58. 1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998;101:527-535.
59. 1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res 2004;1028:9-18.
60. Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E, Saavedra JM: AT 1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 2006;37:1271-1276.
61. + pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production. Endocrinology 1992;130:1637-1644.
62. Xu X, Xiao JC, Luo LF, Wang S, Zhang JP, Huang JJ, Liu ML, Liu CG, Xu KQ, Li YJ, Song HP: Effects of ovariectomy and 17β-estradiol treatment on the renin-angiotensin system, blood pressure, and endothelial structure. Int J Cardiol 2007 [Epub ahead of print].
63. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I: Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 1997;272:F299-F304.
64. Wang DH, Qiu J, Hu Z: Differential regulation of angiotensin II receptor subtypes in the adrenal gland: role of aldosterone. Hypertension 1998;32:65-70.
65. Mazzocchi G, Malendowicz LK, Gottardo G, Rebuffat P, Nussdorfer GG: Angiotensin-II stimulates DNA synthesis in rat adrenal zona glomerulosa cells: receptor subtypes involved and possible signal transduction mechanism. Endocr Res 1997;23:191-203.
66. Gauthier KM, Zhang DX, Edwards EM, Holmes B, Campbell WB: Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocrinology 2005;146:3319-3324.
67. Kholer C, Berkowitz BA, Spector S: Sex hormones and tyrosine hydroxylase activity in vascular and adrenal tissue. Endocrinology 1975;97:1316-1320.
68. Lam K-K, Lee Y-M, Hsiao G, Chen S-Y, Yen M-H: Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 2006;13:294-302.
69. Miyazaki-Akita A, Hayashi T, Ding QF, Shiraishi H, Nomura T, Hattori Y, Iguchi A: 17β-Estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease. J Pharmacol Exp Ther 2007;320:591-598.
70. Maharjan S, Serova L, Sabban EL: Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors α and β and interactions with cyclic AMP. J Neurochem 2005;93:1502-1514.
71. Nankova BB, Rivkin M, Kelz M, Nestler EJ, Sabban EL: Fos-related antigen 2: potential mediator of the transcriptional activation in rat adrenal medulla evoked by repeated immobilization stress. J Neurosci 2000;20:5647-5653.
72. Milde-Langosch K: The Fos family of transcription factors and their role in tumorigenesis. Eur J Cancer 2005;41:2449-2461.
73. Wang X, Belguise K, Kersual N, Kirsch KH, Mineva ND, Galtier F, Chalbos D, Sonenshein GE: Oestrogen signaling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 2007;9:470-478.
74. 1 receptor gene expression in vitro and in vivo. Circulation 1998;97:2197-2201.
75. Seltzer A, Pinto JE, Viglione PN, Correa FM, Libertun C, Tsutsumi K, Steele MK, Saavedra JM: Estrogens regulate angiotensin-converting enzyme and angiotensin receptors in female rat anterior pituitary. Neuroendocrinology 1992;55:460-467.